These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9423264)

  • 1. A distribution of tumor size at detection: an application to breast cancer data.
    Tsodikov AD; Asselain B; Yakovlev AY
    Biometrics; 1997 Dec; 53(4):1495-502. PubMed ID: 9423264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A distribution of tumor size at detection and its limiting form.
    Yakovlev AY; Hanin LG; Rachev ST; Tsodikov AD
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6671-5. PubMed ID: 8692876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The University of Rochester model of breast cancer detection and survival.
    Hanin LG; Miller A; Zorin AV; Yakovlev AY
    J Natl Cancer Inst Monogr; 2006; (36):66-78. PubMed ID: 17032896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stochastic model for the sizes of detectable metastases.
    Hanin L; Rose J; Zaider M
    J Theor Biol; 2006 Dec; 243(3):407-17. PubMed ID: 16930629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cure rate survival model under a hybrid latent activation scheme.
    Borges P; Rodrigues J; Louzada F; Balakrishnan N
    Stat Methods Med Res; 2016 Apr; 25(2):838-56. PubMed ID: 23264557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphometric analysis of mammographic images in clinical oncology].
    Campisi C; Soluri A; Terenzi S; Zappalà A; Zinevrakis S
    Clin Ter; 1995 Nov; 146(11):683-90. PubMed ID: 8720345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.
    Plevritis SK; Sigal BM; Salzman P; Rosenberg J; Glynn P
    J Natl Cancer Inst Monogr; 2006; (36):86-95. PubMed ID: 17032898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Growth rate of breast cancer, implication for early detection and therapeutic effects].
    von Fournier D; Abel U; Spratt JA; Spratt JS; Anton HW
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):286-90. PubMed ID: 8050689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive breast cancer: mammographic measurement.
    Flanagan FL; McDermott MB; Barton PT; Pilgram TK; Dehdashti F; Wick MR; Monsees BS
    Radiology; 1996 Jun; 199(3):819-23. PubMed ID: 8638011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of breast cancer in an incident cancer population.
    Schmitt EL; Threatt B
    AJR Am J Roentgenol; 1984 Aug; 143(2):403-6. PubMed ID: 6611076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration.
    Chia YL; Salzman P; Plevritis SK; Glynn PW
    Stat Methods Med Res; 2004 Dec; 13(6):507-24. PubMed ID: 15587436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling cancer detection: tumor size as a source of information on unobservable stages of carcinogenesis.
    Bartoszyński R; Edler L; Hanin L; Kopp-Schneider A; Pavlova L; Tsodikov A; Zorin A; Yakovlev AY
    Math Biosci; 2001 Jun; 171(2):113-42. PubMed ID: 11395047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth velocity of breast carcinoma and radiographic "early diagnoses"].
    Fournier DV; Kuttig H; Kubli F; Prager P; Stolpe H; Maier A; Hüter J
    Strahlentherapie; 1976 Apr; 151(4):318-32. PubMed ID: 1265781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of mammographically detected breast cancers.
    Sener SF; Winchester DJ; Winchester DP; Kurek R; Motykie G; Martz CH; Rabbitt S
    Am Surg; 1999 Aug; 65(8):731-5; discussion 735-6. PubMed ID: 10432082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical models of tumour onset and growth for modern breast cancer screening cohorts.
    Strandberg JR; Humphreys K
    Math Biosci; 2019 Dec; 318():108270. PubMed ID: 31627176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved determination of breast cancer size in mammography.
    Sphiris N; Panayiotakis G; Proimos B; Likaki H; Tzoracoleftherakis E
    Technol Health Care; 1996 Aug; 4(2):163-8. PubMed ID: 8885094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A natural history model of stage progression applied to breast cancer.
    Plevritis SK; Salzman P; Sigal BM; Glynn PW
    Stat Med; 2007 Feb; 26(3):581-95. PubMed ID: 16598706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
    Seppänen J; Heinävaara S; Holli K; Hakulinen T
    Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.
    Mandelblatt J; Schechter CB; Lawrence W; Yi B; Cullen J
    J Natl Cancer Inst Monogr; 2006; (36):47-55. PubMed ID: 17032894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.